Polianta Ltd Makes New Investment in Cigna Group $CI

Polianta Ltd purchased a new stake in shares of Cigna Group (NYSE:CI) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 5,700 shares of the health services provider’s stock, valued at approximately $1,568,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CI. Harbor Capital Advisors Inc. boosted its holdings in shares of Cigna Group by 119.5% in the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after buying an additional 49 shares during the last quarter. Beacon Financial Strategies CORP purchased a new stake in Cigna Group during the fourth quarter valued at approximately $28,000. Collier Financial purchased a new stake in Cigna Group during the third quarter valued at approximately $34,000. Founders Capital Management raised its position in Cigna Group by 53.0% in the third quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock worth $44,000 after acquiring an additional 53 shares during the period. Finally, Twin Peaks Wealth Advisors LLC bought a new position in Cigna Group in the second quarter worth approximately $52,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This represents a 6.60% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.60% of the stock is currently owned by insiders.

Cigna Group Price Performance

Shares of NYSE:CI opened at $257.97 on Tuesday. The firm has a market cap of $67.98 billion, a price-to-earnings ratio of 11.63, a P/E/G ratio of 0.91 and a beta of 0.27. The firm has a fifty day moving average price of $276.81 and a 200 day moving average price of $279.82. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The company had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. Cigna Group’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, sell-side analysts expect that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Thursday, March 5th were given a $1.56 dividend. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CI. Sanford C. Bernstein raised shares of Cigna Group from a “market perform” rating to an “outperform” rating and boosted their price objective for the company from $307.00 to $358.00 in a research report on Thursday, March 12th. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Piper Sandler lowered their target price on Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Truist Financial boosted their price target on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Finally, Mizuho set a $325.00 price target on Cigna Group in a research report on Friday, January 9th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $333.11.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.